Abstract Title: currently loading...

information currently loading...

close
Loading ... please wait
timer Loading ... please wait

Free Paper Session 11: New Drug Treatment & Technology I

16:40 - 18:00 | 21 September | Room: Room C1.

Back to Previous

16:30Evaluation of a portable artificial vision device among patients affected by retinitis pigmentosa implanted with Argus II retina prosthesis
F. Patelli Italy
16:36Assessing the effectiveness of fluocinolone acetonide (0.2 micrograms/day FAc) and dexamethasone (DEX 700 micrograms) steroid implants in DME phase III pivotal trials using the areaunderthecurve (AUC) method: The constant analysis
J. Zarranz-Ventura Spain
16:42Systemic biodistribution and intravitreal pharmacokinetic properties of bevacizumab, ranibizumab and aflibercept in a nonhuman primate model
J. Christoforidis United States
16:48Fluorescence lifetime imaging ophthalmoscopy: Quantitative analysis in macular telangiectasia type 2
Y. Solberg Switzerland
16:54Smart Phone Ophthalmoscopy a potential replacement for the direct ophthalmoscope
S. Mamtora United Kingdom
17:00Use of biosimiliar ranibuzumab( razumab) in macular pathology
R. Shah India
17:06Silicone oil microdroplets contamination source for intravitreal injections
J. Olea Vallejo Spain
17:12Subtreshold Laser Treatment in chronic central serous chorioretinopathy: a prospective interventional study
B. Schworm Germany
17:18Antiinflammatory effects of the PIGF neutralizing antibody THR317 in patients with diabetic macular edema
M. Porcu Belgium
17:24Year 3 results and agestratified analyses for a phase 3 trial of voretigene neparvovec in RPE65 mutation–associated inherited retinal disease
B. LeRoy Belgium
17:30Improved retinal sensitivity in a Phase 2 choroideremia gene therapy trial
M. Fischer Germany
17:36Biocompatibility and stability of a viral vector used in retinal gene therapy
M. Patricio United Kingdom
17:42Subretinal implantations of PRIMA wireless photovoltaic chip, a new surgical technique for atrophic dry agerelated macular degeneration: Technical feasibility and early results
Y. Le Mer France
17:48Intraocular pressure (IOP) after intravitreal dexamethasone implant (ozurdex) In different geographic populations in real world GEODEXIOP study
A. Sharma India
Back to Previous

Sign up to EURETINA


© EURETINA All rights reserved
Loading please wait